Porretti et al. [13], who studied the effects of six-month rhGH replacement therapy in adults with severe GHD, both isolated and in association with other multiple deficiencies, found that GH deficit, and consequently low IGF-1 levels, could mask central hypothyroidism in those patients. The gene discussed is IGF1; the disease is Central hypothyroidism.